Edizone SB 250mg/125mg Injection
Marketer
Scott Edil Pharmacia Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Edizone SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration should always be under medical guidance; adhere strictly to the prescribed dosage schedule. Complete the full course of treatment, even with symptom improvement, as premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (skin rash, itching, swelling, dyspnea, etc.). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your physician may order blood tests and imaging studies to monitor treatment response.
Uses of Edizone SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Edizone SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Edizone SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Edizone SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Edizone SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Edizone SB 250 mg/125 mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this by neutralizing bacterial enzymes that would otherwise counteract Ceftriaxone's effects, thus improving its efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Edizone SB 250 mg/125 mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Edizone SB 250 mg/125 mg Injection is typically regarded as safe. Preclinical trials in animals revealed minimal or no harm to the fetus; clinical data in humans, however, remain scarce.
Breast feedingCAUTION
The administration of Edizone SB 250 mg/125 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Edizone SB 250 mg/125 mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Edizone SB 250 mg/125 mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Edizone SB 250 mg/125 mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alterations for Edizone SB 250 mg/125 mg Injection are unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Edizone SB 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Edizone SB 250 mg/125 mg Injection, seek medical advice.
Facts to Know About Edizone SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently